Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
SIGA vs GOVX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
SIGA Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)
SIGA Overall Winner
6-Pillar Tally: SIGA 6 – 0 GOVX
Matrix Metrics: SIGA 7 – 3 GOVX
As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over GeoVax Labs, Inc. New (GOVX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SIGA carries a Unified Composite Score of 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin), whereas GOVX carries 26.5/100 (SELL) at $1.91 (9.7x Forward P/E, 0.0% operating margin).
- Technical & Structure Timing Caution: SIGA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile GOVX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 72.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About SIGA vs GOVX
SIGA
Head-to-Head Winner
SIGA Technologies Inc.
$2.65
-5.36% 1D
Market Cap
$187.9M
TTM Revenue
$52M
Forward P/E
2.5x
Beta / 30D Vol
0.75β · 65% Vol
Unified Composite Score
47.5
HOLD
Tech 40.0
Fund 56.0
Flow 69.0
Mom 64.0
Weinstein Technical Phase
Markdown · Sell / avoid
GOVX
GeoVax Labs, Inc. New
$1.91
-4.02% 1D
Market Cap
$1.1M
TTM Revenue
N/A
Forward P/E
9.7x
Beta / 30D Vol
16.91β · 6225% Vol
Unified Composite Score
26.5
SELL
Tech 50.0
Fund 30.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (SIGA 6 – 0 GOVX)
1. Valuation Multiples
SIGA
Forward P/E
2.5x
9.7x
Trailing P/E
N/M
9.7x
PEG Ratio
3.37x
N/M
EV / Revenue
1.4x
N/M
2. Growth & Scale
SIGA
Revenue Growth (YoY)
-49.7%
-100.0%
Earnings Growth (YoY)
-65.3%
+0.0%
TTM Revenue (USD)
$52M
N/A
Market Cap
$187.9M
$1.1M
3. Profitability & Quality
SIGA
Gross Margin
23.4%
N/A
Operating Margin
-14.2%
0.0%
Net Profit Margin
1.3%
0.0%
Return on Equity (ROE)
0.4%
-891.6%
4. Balance Sheet & Cash Flow
SIGA
Cash Generation (TTM)
-$12M
N/A
Cash Flow Margin
-22.1%
N/A
Net Cash / Leverage
$116M Net Cash
$2.8M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
SIGA
Options Structure Phase
CONSOLIDATION
UNCLASSIFIED
Current IV / %ile
81.4% (8th %ile)
N/A (N/A)
Put/Call OI Skew
0.04x (Call-Skewed)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
SIGA
OpEx & R&D Intensity
37.6% of Rev ($20M)
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Drug Manufacturers - Specialty & Generic Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: SIGA (7) vs GOVX (3)| Institutional Metric | SIGA | GOVX | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $187.9M | $1.1M | SIGA | |
| Trailing P/E Ratio | N/M | 9.7x | GOVX | |
| Forward P/E Ratio | 2.5x | 9.7x | SIGA | |
| Revenue Growth (YoY) | -49.7% | -100.0% | SIGA | |
| Operating Margin (TTM) | -14.2% | 0.0% | GOVX | |
| Net Profit Margin | 1.3% | 0.0% | SIGA | |
| Return on Equity (ROE) | 0.4% | -891.6% | SIGA | |
| 52-Week Range Position | 3% ($3–$7) | 42% ($0–$4) | GOVX | |
| Beta / 30D Volatility | 0.75β · 65% Vol | 16.91β · 6225% Vol | SIGA | |
| Unified Institutional Score | 47.5 / 100 (HOLD) | 26.5 / 100 (SELL) | SIGA | |
| Trailing 12M Revenue (USD) | $52M | N/A | Scale | |
| Gross Profit Margin (TTM) | 23.4% | N/A | Quality | |
| PEG Ratio & EV / Revenue | 3.37x PEG · 1.4x EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$12M ($116M Net Cash) | N/A ($2.8M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
GOVX +737.63 pp
3M Horizon
GOVX +208.68 pp
6M Horizon
GOVX +13.19 pp
1Y Horizon
GOVX +423.75 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SIGA Revenue | GOVX Revenue | SIGA Op. Margin | GOVX Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $480M | $0M | 74.4% | -266.1% | SIGA |
| FY2019 | $30M | $0M | -8.7% | -201.8% | SIGA |
| FY2020 | $120M | $0M | 67.6% | -154.5% | SIGA |
| FY2021 | $130M | $0M | 66.7% | -4862.7% | SIGA |
| FY2022 | $110M | $0M | 38.5% | -17207.5% | SIGA |
| FY2023 | $140M | N/A | 59.8% | N/A | SIGA |
| FY2024 | $140M | $0M | 50.4% | -635.8% | SIGA |
| FY2025 | $90M | $0M | 25.1% | -869.3% | SIGA |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
SIGA
CONSOLIDATION
Current IV
81.4%
IV Percentile
8th %ile
Put/Call OI Skew
0.04x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact SIGA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
GOVX
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact GOVX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
SIGA Moat Profile
Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
OpEx & R&D Reinvestment
37.6% of Rev ($20M)
90D Engineering Disclosures
0 Published
GOVX Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ SIGA vs GOVX Key Questions & Quantitative Answers
As of Nov 19, 2026, SIGA Technologies Inc. (SIGA) is the stronger overall head-to-head candidate over GeoVax Labs, Inc. New (GOVX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SIGA carries a Unified Composite Score of 47.5/100 (HOLD) at $2.65 (2.5x Forward P/E, -14.2% operating margin), whereas GOVX carries 26.5/100 (SELL) at $1.91 (9.7x Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: SIGA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile GOVX trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 72.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SIGA leads the Growth & Scale pillar: SIGA posts -49.7% YoY revenue growth and -65.3% YoY earnings growth on $52M TTM revenue (23.4% gross margin, -14.2% operating margin), compared with GOVX at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SIGA cumulative revenue shifted -81.2% while GOVX shifted N/A. In operating R&D and SG&A reinvestment, SIGA deploys 37.6% of Rev ($20M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GOVX.
SIGA screens cheaper on headline valuation multiples. SIGA trades at 2.5x Forward P/E, N/M Trailing P/E, 3.37x PEG, and 1.4x EV/Revenue (-22.1% FCF margin), whereas GOVX trades at 9.7x Forward P/E, 9.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SIGA (0.4% ROE) versus GOVX (-891.6% ROE) capital efficiency.
In options market volatility and institutional positioning, SIGA carries 81.4% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.04x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 65% Vol realized risk). By comparison, GOVX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (16.91β · 6225% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
GOVX vs SIGA · Reverse Pair
SIGA vs EBS
· Sector Peer
SIGA vs RIGL
· Sector Peer
GOVX vs AEMD
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking